Read the latest positive news, breakthroughs, and inspiring stories about heart disease, curated daily by BrightWire.
Four leading medical organizations just created the first-ever framework linking women's heart health to every life stage, from puberty through menopause. The groundbreaking guide helps doctors catch warning signs early and could prevent over 80% of heart attacks in women.
Scientists just discovered that tiny bursts of everyday movement—like fidgeting, carrying groceries, or doing dishes—can protect your heart in just four minutes a day. No gym required.
Scotland has approved a groundbreaking injection for a rare, fatal heart condition that reduced deaths by more than a third in clinical trials. The drug offers hope to thousands living with a disease that has had almost no treatment options.
A new AI tool can spot early signs of heart failure and valve disease from routine heart rhythm tests, potentially saving thousands of lives through faster diagnosis. The breakthrough could end months-long waits for specialized scans by flagging high-risk patients immediately.
A groundbreaking heart implant just approved in Japan restored normal artery function and slashed heart-related deaths by 88% in clinical trials. The DynamX bioadaptor represents the first device to fix both blood flow and artery movement after blockage treatment.
After two open-heart surgeries and a life-saving mechanical valve, 2-year-old Blake is thriving on playgrounds across Palm Beach County. Her family's journey shows how medical miracles and community support transform fear into hope.
Simple blood and urine tests combined with early treatment can now break the dangerous cycle between heart disease and kidney disease. European doctors just released breakthrough guidelines that could help 100 million people avoid serious complications.
Software developed by Imperial College London can spot heart disease in seconds using standard ECG scans, potentially saving millions of lives. The "superhuman" tool identified 93% of cases in a 67,000-patient trial.
A breakthrough medication could become the first FDA-approved treatment for a common inherited heart disease affecting hundreds of thousands of people. Patients who've lived with limiting symptoms finally have reason for hope.
A newly tested Novartis drug successfully reduced inflammation markers that contribute to heart disease, bringing hope for better cardiovascular treatments. Higher doses showed even stronger results, proving the medicine works as designed.
A single gene-editing treatment cut cholesterol levels in half for an entire year, offering hope for millions who struggle with daily heart disease medication. The breakthrough could transform how doctors treat America's leading killer.
After 27 years, biotech company Cytokinetics could win its second FDA approval in record time with a groundbreaking heart drug. The medication would be the first treatment specifically designed for a type of inherited heart disease that affects thousands of Americans.